GM
Therapeutic Areas
Juniper Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Precision Neuromodulation Platform | Pelvic Health Disorders (e.g., Urinary Incontinence, Bowel Incontinence, Pelvic Pain) | Pre-clinical |
Leadership Team at Juniper Biomedical
DN
David N. Constantine
Co-Founder & CEO
MR
Mario Romero-Ortega, PhD
Co-Founder & Chief Science Officer
JC
Jayme Coates, MS, MBA
Chief Operating Officer
JD
Jessica DeLong, MD, FACS
Chief Medical Officer
RS
Robert Swain, PhD
Clinical & Regulatory Affairs